TENX Tenax Therapeutics, Inc.
Tenax Therapeutics, Inc. (TENX) Hedge Fund Activity
This view isolates hedge funds from the broader institutional ownership shown on the Institutional tab. A pension fund tracking an index may have no view on a stock; when a hedge fund builds or exits a position, that decision can carry information. This page measures those changes. Positions as of June 30, 2026.
Based on quarterly 13F long-equity filings. Changes compare reported quarter-end positions; filings can be reported up to 45 days later and do not represent a fund's complete exposure.
Most significant moves
Ranked by conviction, not size — how much of the fund's own book the position represents, how far it moved, and what kind of fund made it.
| Fund | Action | Shares changed | Change | Est. value | Portfolio wt. | Score |
|---|---|---|---|---|---|---|
| Braidwell Growth Healthcare | New | +584.4K | — | $8.5M | 0.3% | 60 |
| Balyasny Asset Management L.P. | Sold Out | -194.6K | -100.0% | $2.8M | 0.0% | 59 |
| Armistice Capital Long/Short Healthcare | Sold Out | -478.8K | -100.0% | $7.0M | 0.0% | 56 |
| Squarepoint Ops LLC Quant | New | +33.3K | — | $485.0K | 0.0% | 54 |
| RTW Investments Growth Healthcare | Increased | +326.3K | +88.1% | $4.7M | 0.1% | 54 |
| CITADEL ADVISORS LLC Quant | Increased | +576.0K | +377.7% | $8.4M | 0.0% | 54 |
| Walleye Capital Long/Short Quant | New | +105.2K | — | $1.5M | 0.0% | 53 |
| Caption Management Quant | New | +255.0K | — | $3.7M | 0.1% | 53 |
| TWO SIGMA INVESTMENTS, LP Quant | Increased | +284.8K | +415.2% | $4.1M | 0.0% | 53 |
| Quadrature Capital Quant | Sold Out | -15.5K | -100.0% | $225.1K | 0.0% | 52 |
Most significant buyers
By move score, not size.
- Braidwell
- Squarepoint Ops LLC
- RTW Investments
- CITADEL ADVISORS LLC
- Walleye Capital
Most significant sellers
By move score, not size.
- Balyasny Asset Management L.P.
- Armistice Capital
- Quadrature Capital
- Logos Global Management
- Boothbay Fund Management
Hedge fund positions
| Fund | Tier | Shares | Previous | Change | Change % | Portfolio wt. | Action | Score |
|---|---|---|---|---|---|---|---|---|
| Braidwell | 2 | 584.4K | 0 | +584.4K | — | 0.3% | New | 60 |
| Balyasny Asset Management L.P. | 2 | 0 | 194.6K | -194.6K | -100.0% | 0.0% | Sold Out | 59 |
| Armistice Capital | 3 | 0 | 478.8K | -478.8K | -100.0% | 0.0% | Sold Out | 56 |
| Squarepoint Ops LLC | 2 | 33.3K | 0 | +33.3K | — | 0.0% | New | 54 |
| RTW Investments | 1 | 696.6K | 370.2K | +326.3K | +88.1% | 0.1% | Increased | 54 |
| CITADEL ADVISORS LLC | 1 | 728.6K | 152.5K | +576.0K | +377.7% | 0.0% | Increased | 54 |
| Walleye Capital | 3 | 105.2K | 0 | +105.2K | — | 0.0% | New | 53 |
| Caption Management | 3 | 255.0K | 0 | +255.0K | — | 0.1% | New | 53 |
| TWO SIGMA INVESTMENTS, LP | 2 | 353.4K | 68.6K | +284.8K | +415.2% | 0.0% | Increased | 53 |
| Quadrature Capital | 3 | 0 | 15.5K | -15.5K | -100.0% | 0.0% | Sold Out | 52 |
| Man Group | 3 | 49.0K | 0 | +49.0K | — | 0.0% | New | 52 |
| Qube Research & Technologies Ltd | 2 | 429.9K | 28.3K | +401.6K | +1419.9% | 0.0% | Increased | 51 |
| Quinn Opportunity Partners | 4 | 40.0K | 0 | +40.0K | — | 0.0% | New | 49 |
| Trexquant Investment | 3 | 321.6K | 50.7K | +270.9K | +534.2% | 0.0% | Increased | 47 |
| Quantbot Technologies | 4 | 10.7K | 0 | +10.7K | — | 0.0% | New | 45 |
| MILLENNIUM MANAGEMENT LLC | 2 | 876.2K | 533.9K | +342.3K | +64.1% | 0.0% | Increased | 44 |
| MARSHALL WACE, LLP | 2 | 585.6K | 352.6K | +233.0K | +66.1% | 0.0% | Increased | 44 |
| Logos Global Management | 2 | 300.0K | 625.0K | -325.0K | -52.0% | 0.2% | Reduced | 42 |
| Woodline Partners LP | 2 | 531.3K | 323.9K | +207.3K | +64.0% | 0.0% | Increased | 41 |
| Perceptive Advisors | 1 | 1.7M | 1.4M | +252.2K | +17.4% | 0.4% | Increased | 38 |
| ExodusPoint Capital Management | 3 | 184.5K | 120.5K | +64.0K | +53.1% | 0.0% | Increased | 35 |
| Point72 Asset Management, L.P. | 1 | 556.8K | 534.0K | +22.8K | +4.3% | 0.0% | Increased | 30 |
| RENAISSANCE TECHNOLOGIES LLC | 1 | 164.0K | 152.6K | +11.4K | +7.5% | 0.0% | Increased | 29 |
| ADAR1 Capital Management | 3 | 220.5K | 213.5K | +7.0K | +3.3% | 0.2% | Increased | 24 |
| Boothbay Fund Management | 4 | 311.1K | 366.8K | -55.7K | -15.2% | 0.1% | Reduced | 22 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 2 | 540.1K | 540.1K | 0 | +0.0% | 0.0% | Unchanged | 20 |
| Biotechnology Value Fund | 1 | 339.5K | 339.5K | 0 | +0.0% | 0.1% | Unchanged | 23 |
| Integral Health Asset Management | 2 | 167.0K | 167.0K | 0 | +0.0% | 0.1% | Unchanged | 21 |
| Vestal Point Capital | 1 | 53.4K | 53.4K | 0 | +0.0% | 0.0% | Unchanged | 23 |
| Verition Fund Management | 2 | 13.6K | 13.6K | 0 | +0.0% | 0.0% | Unchanged | 18 |
Every fund above opens. Subscribers can see any manager's whole portfolio — every position, its weight, and what they bought, trimmed and exited last quarter.
Sign in or subscribeHedge funds are identified from their 13F filings, which are due 45 days after quarter end and cover long U.S.-listed equity positions only. A fund's short book never appears, so a reduced position can mean a changed view or a changed hedge — the filing doesn't say which.